|
1
|
Amar A, Rapoport A, Curioni OA, et al:
Prognostic value of regional metastasis in squamous cell carcinoma
of the tongue and floor of mouth. Braz J Otorhinolaryngol.
79:734–737. 2013.(In English, and Portuguese). View Article : Google Scholar
|
|
2
|
Huang Z, Huang H, Li H, et al: EMMPRIN
expression in tongue squamous cell carcinoma. J Oral Pathol Med.
38:518–523. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qu JH, Chang XJ, Lu YY, et al:
Overexpression of metastasis-associated in colon cancer 1 predicts
a poor outcome of hepatitis B virus-related hepatocellular
carcinoma. World J Gastroenterol. 18:2995–3003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stein U, Burock S, Herrmann P, et al:
Circulating MACC1 transcripts in colorectal cancer patient plasma
predict metastasis and prognosis. PLoS One. 7:e492492012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stein U, Walther W, Arlt F, et al: MACC1,
a newly identified key regulator of HGF-MET signaling, predicts
colon cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar
|
|
6
|
Meng FJ, Li H, Shi HJ, et al: MACC1
down-regulation inhibits proliferation and tumourigenicity of
nasopharyngeal carcinoma cells through Akt/β-catenin signaling
pathway. PLoS One. 8:e608212013. View Article : Google Scholar
|
|
7
|
Shimokawa H, Uramoto H, Onitsuka T, et al:
Overexpression of MACC1 mRNA in lung adenocarcinoma is associated
with postoperative recurrence. J Thorac Cardiovasc Surg.
141:895–898. 2011. View Article : Google Scholar
|
|
8
|
Chundong G, Uramoto H, Onitsuka T, et al:
Molecular diagnosis of MACC1 status in lung adenocarcinoma by
immunohistochemical analysis. Anticancer Res. 31:1141–1145.
2011.PubMed/NCBI
|
|
9
|
Xie C, Wu J, Yun J, et al: MACC1 as a
prognostic biomarker for early-stage and AFP-normal hepatocellular
carcinoma. PLoS One. 8:e642352013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiu J, Huang P, Liu Q, et al:
Identification of MACC1 as a novel prognostic marker in
hepatocellular carcinoma. J Transl Med. 9:1662011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang YP, Qu JH, Chang XJ, et al: High
intratumoral metastasis-associated in colon cancer-1 expression
predicts poor outcomes of cryoablation therapy for advanced
hepatocellular carcinoma. J Transl Med. 11:412013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang R, Shi H, Chen Z, et al: Effects of
metastasis-associated in colon cancer 1 inhibition by small hairpin
RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res.
30:832011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang G, Kang MX, Lu WJ, et al: MACC1: A
potential molecule associated with pancreatic cancer metastasis and
chemoresistance. Oncol Lett. 4:783–791. 2012.PubMed/NCBI
|
|
14
|
Huang Y, Zhang H, Cai J, et al:
Overexpression of MACC1 and its significance in human breast cancer
progression. Cell Biosci. 3:162013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Wang Z, Chen M, et al:
MicroRNA-143 targets MACC1 to inhibit cell invasion and migration
in colorectal cancer. Mol Cancer. 11:232012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Migliore C, Martin V, Leoni VP, et al:
MiR-1 downregulation cooperates with MACC1 in promoting MET
overexpression in human colon cancer. Clin Cancer Res. 18:737–747.
2012. View Article : Google Scholar
|
|
17
|
Guo T, Yang J, Yao J, Zhang Y, Da M and
Duan Y: Expression of MACC1 and c-Met in human gastric cancer and
its clinical significance. Cancer Cell Int. 13:1212013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng HC, Takahashi H, Murai Y, et al:
Upregulated EMMPRIN/CD147 might contribute to growth and
angiogenesis of gastric carcinoma: a good marker for local invasion
and prognosis. Br J Cancer. 95:1371–1378. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vigneswaran N, Beckers S, Waigel S, et al:
Increased EMMPRIN (CD 147) expression during oral carcinogenesis.
Exp Mol Pathol. 80:147–159. 2006. View Article : Google Scholar
|
|
20
|
Huang Z, Tan N, Guo W, et al:
Overexpression of EMMPRIN isoform 2 is associated with head and
neck cancer metastasis. PLoS One. 9:e915962014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhong WD, Han ZD, He HC, et al: CD147,
MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic
factors in human prostate cancer. Oncology. 75:230–236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng PC, Chen X, Zhu HW, et al: Capn4 is
a marker of poor clinical outcomes and promotes nasopharyngeal
carcinoma metastasis via nuclear factor-κB-induced matrix
metalloproteinase 2 expression. Cancer Sci. 105:630–638. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Q, Lan F, Wang X, et al:
IL-1β-induced activation of p38 promotes metastasis in gastric
adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Mol
Cancer. 13:182014. View Article : Google Scholar
|
|
24
|
Moroz A, Delella FK, Almeida R, et al:
Finasteride inhibits human prostate cancer cell invasion through
MMP2 and MMP9 downregulation. PLoS One. 8:e847572013. View Article : Google Scholar
|
|
25
|
Xiao W, Jiang M, Li H, Li C, Su R and
Huang K: Knockdown of FAK inhibits the invasion and metastasis of
Tca8113 cells in vitro. Mol Med Rep. 8:703–707. 2013.PubMed/NCBI
|
|
26
|
Wang X, Sun W, Zhang C, et al: TGF-β1
inhibits the growth and metastasis of tongue squamous carcinoma
cells through Smad4. Gene. 485:160–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zucker S, Hymowitz M, Rollo EE, et al:
Tumorigenic potential of extracellular matrix metalloproteinase
inducer. Am J Pathol. 158:1921–1928. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sienel W, Polzer B, Elshawi K, et al:
Cellular localization of EMMPRIN predicts prognosis of patients
with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Mod Pathol. 21:1130–1138. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bao YN, Cao X, Luo DH, et al:
Urokinase-type plasminogen activator receptor signaling is critical
in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle.
13:1958–1969. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi H, Liu L, Liu L, Geng J, et al:
beta-Elemene inhibits the metastasis of B16F10 melanoma cells by
downregulation of the expression of uPA, uPAR, MMP-2 and MMP-9.
Melanoma Res. 24:99–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Quemener C, Gabison EE, Naimi B, et al:
Extracellular matrix metalloproteinase inducer up-regulates the
urokinase-type plasminogen activator system promoting tumor cell
invasion. Cancer Res. 67:9–15. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lescaille G, Menashi S, Cavelier-Balloy B,
et al: EMMPRIN/CD147 up-regulates urokinase-type plasminogen
activator: implications in oral tumor progression. BMC Cancer.
12:1152012. View Article : Google Scholar : PubMed/NCBI
|
